ClinicalTrials.Veeva

Menu

Nesiritide for Ventilated Congestive Heart Failure (HENCHF)

Fudan University logo

Fudan University

Status

Unknown

Conditions

Using Nesiritide
Venous Return
Mechanical Ventilation
Cardiac Function
Congestive Heart Failure

Treatments

Drug: Nesiritide

Study type

Observational

Funder types

Other

Identifiers

NCT04455477
B2020-056R

Details and patient eligibility

About

The congestive heart failure is a common disease among patients who receive cardiac surgery and may lead to prolonged ventilation support. Nesiritide was a potential therapy for congestive heart failure. This study aimed to compare the Nesiritide induced hemodynamical status changes among congestive heart failure patients with invasive ventilation support.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age≥18 years;
  • Congestive Heart Failure;
  • With mechanical ventilation;
  • With hemodynamic monitoring devices;
  • The physicians made the decision of using Nesiritide.

Exclusion criteria

  • Unstable hemodynamic status;
  • Severe renal dysfunction.

Trial contacts and locations

1

Loading...

Central trial contact

Zhe Luo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems